BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31952211)

  • 1. Open Data for Differential Network Analysis in Glioma.
    Jean-Quartier C; Jeanquartier F; Holzinger A
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational screening of potential glioma-related genes and drugs based on analysis of GEO dataset and text mining.
    Jiang Z; Shi Y; Tan G; Wang Z
    PLoS One; 2021; 16(2):e0247612. PubMed ID: 33635875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the gene-protein interaction network in glioma.
    Zhou C; Teng WJ; Zhuang J; Liu HL; Tang SF; Cao XJ; Qin BN; Wang CC; Sun CG
    Genet Mol Res; 2015 Nov; 14(4):14196-206. PubMed ID: 26600477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression.
    Ye T; Cheng Y; Li C
    Comput Math Methods Med; 2021; 2021():5086236. PubMed ID: 34367317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
    Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
    Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
    Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
    Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
    Akçay S; Güven E; Afzal M; Kazmi I
    Gene; 2022 May; 824():146395. PubMed ID: 35283227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
    Xia P; Li Q; Wu G; Huang Y
    J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Hub Genes and Key Pathways Associated with Anti-
    Arya KR; Bharath Chand RP; Abhinand CS; Nair AS; Oommen OV; Sudhakaran PR
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening critical genes associated with malignant glioma using bioinformatics analysis.
    Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z
    Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated systems-genetic analyses reveal a network target for delaying glioma progression.
    Laaniste L; Srivastava PK; Stylianou J; Syed N; Cases-Cunillera S; Shkura K; Zeng Q; Rackham OJL; Langley SR; Delahaye-Duriez A; O'Neill K; Williams M; Becker A; Roncaroli F; Petretto E; Johnson MR
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1616-1638. PubMed ID: 31420939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revealing the potential pathogenesis of glioma by utilizing a glioma associated protein-protein interaction network.
    Pan W; Li G; Yang X; Miao J
    Pathol Oncol Res; 2015 Apr; 21(2):455-62. PubMed ID: 25410026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening candidate genes associated with bladder cancer using DNA microarray.
    Xu A; Wang C; Sun S
    Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells.
    Du C; Pan P; Jiang Y; Zhang Q; Bao J; Liu C
    World J Surg Oncol; 2016 Oct; 14(1):258. PubMed ID: 27716259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.